NAOV Stock Summary and Trading Ideas (Nanovibronix | NASDAQ:NAOV)

NanoVibronix Inc manufactures noninvasive biological response-activating devices that target biofilm prevention, pain therapy, and wound healing and can be administered at home, without the assistance of medical professionals. Its primary products are UroShield; PainShield; and WoundShield. Each of its UroShield, PainShield, and WoundShield products employs a small, disposable transducer that transmits low-frequency, low-intensity ultrasound acoustic waves that seek to repair and regenerate tissue, musculoskeletal and vascular structures, and decrease biofilm formation on urinary catheters and associated urinary tract infections. The company derives revenues from selling its products directly to patients, through distributor agreements.

Nanovibronix trades on the NASDAQ stock market under the symbol NAOV.

As of January 12, 2026, NAOV stock price was flat at $4.02 with million shares trading.

NAOV has a beta of 1.81, meaning it tends to be more sensitive to market movements. NAOV has a correlation of 0.02 to the broad based SPY ETF.

NAOV has a market cap of $4.37 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, NAOV traded as high as $836.00 and as low as $3.55.

NAOV has underperformed the market in the last year with a price return of -93.3% while the SPY ETF gained +19.2%. NAOV has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -42.4% and 0.0%, respectively, while the SPY returned +3.9% and +0.7%, respectively.

NAOV support price is $3.97 and resistance is $4.07 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NAOV shares will trade within this expected range on the day.